Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-24-001035
Filing Date
2024-09-20
Accepted
2024-09-20 16:15:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #7 d79047707.htm SC 13D/A 33623
  Complete submission text file 0000899140-24-001035.txt   35329
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Subject) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89598 | Film No.: 241313556
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587
Business Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 82-2-920-8184
DONG-A ST CO., LTD (Filed by) CIK: 0001799260 (see all company filings)

EIN.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D/A